Endocrinology, Vol 131, 2581-2587, Copyright © 1992 by Endocrine Society

ARTICLES

Specificity of steroid binding in New World primate B95-8 cells with a vitamin D-resistant phenotype

MA Gacad and JS Adams
Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, University of California School of Medicine, Los Angeles 90049.

We recently described the existence of a competitive binding component in vitamin D-resistant New World primate cells that has a relatively low affinity (Kd, approximately 10(-8) M) but high capacity for 1,25- dihydroxyvitamin D3 [1,25-(OH)2D3] compared to that possessed by the vitamin D receptor (VDR). Here we show that this binding component is capable of binding a vitamin D3 metabolite other than 1,25-(OH)2D3 as well as steroid hormones structurally disparate from vitamin D3 sterols. We studied the binding of [3H]1,25-(OH)2D3 and [3H]25- hydroxyvitamin D3 ([3H]25OHD3) in extracts of the vitamin D-resistant marmoset lymphoblastic cell line B95-8 in the presence and absence of potential competitive ligands, including 25OHD3, 1,25-(OH)2D3, 17 beta- estradiol, testosterone, and progesterone, at concentrations ranging from 1-100 nM. Compared to extracts containing the authentic VDR, extracts of B95-8 cells bound 180% more 1,25-(OH)2D3 and 12-fold more 25OHD3 on a weight basis. The affinity of this binder for 25OHD3 was 2.2 times as great as its affinity for 1,25-(OH)2D3. Further, at concentrations approaching the Kd of this binder for 1,25-(OH)2D3, 25OHD3 was 3 times more effective than 1,25-(OH)2D3 in competing with [3H]1,25-(OH)2D3 for binding. This binder eluted from a Sephadex G-100 column with an apparent mol wt of 58 kilodaltons, and pooled elution fractions from the column encompassing this mol wt range were capable of inhibiting binding of 1,25-(OH)2D3 to the VDR by 65%. Competitive steroid binding analyses showed estradiol to be at least as effective as 1,25-(OH)2D3 in inhibition of [3H]1,25-(OH)2D3 binding; homologous binding studies with 17 beta-estradiol as labeled and competitive ligand demonstrated that concentrations of the gonadal steroid that successfully displaced [3H]1,25-(OH)2D3 also displaced 17 beta-[3H] estradiol. Using [3H]25OHD3 as the labeled ligand and a more extensive array of competitive ligands, the rank order of steroid binding was 25OHD3 > 1,25-(OH)2D3 > or = estradiol = progesterone = testosterone. These results suggest that the phenotype of steroid hormone resistance in New World primates may result from the overexpression of an intracellular 58-kilodalton protein(s) that interferes with the steroid- receptor interaction by competing for ligand binding.

This article has been cited by other articles:

				S. Wu, S. Ren, H. Chen, R. F. Chun, M. A. Gacad, and J. S. Adams Intracellular Vitamin D Binding Proteins: Novel Facilitators of Vitamin D-Directed Transactivation Mol. Endocrinol., September 1, 2000; 14(9): 1387 - 1397. [Abstract] [Full Text]

				M. A. Gacad, H. Chen, J. E. Arbelle, T. LeBon, and J. S. Adams Functional Characterization and Purification of an Intracellular Vitamin D-binding Protein in Vitamin D-resistant New World Primate Cells. AMINO ACID SEQUENCE HOMOLOGY WITH PROTEINS IN THE HSP-70 FAMILY J. Biol. Chem., March 28, 1997; 272(13): 8433 - 8440. [Abstract] [Full Text] [PDF]

				H. Chen, B. Hu, E. A. Allegretto, and J. S. Adams The Vitamin D Response Element-binding Protein. A NOVEL DOMINANT-NEGATIVE REGULATOR OF VITAMIN D-DIRECTED TRANSACTIVATION J. Biol. Chem., November 3, 2000; 275(45): 35557 - 35564. [Abstract] [Full Text] [PDF]